İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

SAKİN TEKİN

DOKTOR ÖĞRETİM ÜYESİ

ZONGULDAK BÜLENT ECEVİT ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 108
  • Proje 0
  • Kitap 9
  • Bildiri 62
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 25 Q2 23 Q3 11 Q4 22
WoS (JCR) Q1 13 Q2 25 Q3 15 Q4 20
TR Index 33 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 8
Ort. yüzdelik 60.4%
Üst %1 payı 0.0%
Üst %10 payı 36.4%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 108 yayın

Scopus (SJR)
Q1 25 Q2 23 Q3 11 Q4 22
WoS (JCR)
Q1 13 Q2 25 Q3 15 Q4 20
TR Index
33 makale

Makale listesi

  1. 2024 The impact of microscopic extrathyroidal extension on the clinical outcome of classic subtype papillary thyroid microcarcinoma: a multicenter study Endocrine DOI 10.1007/s12020-023-03533-1 YÖKSİS SJR Q2 JCR Q2
  2. 2024 Disease-free survival and the prognostic factors affecting disease-free survival in patients with medullary thyroid carcinoma: a multicenter cohort study. Endocrine DOI 10.1007/s12020-024-03809-0 YÖKSİS SJR Q2 JCR Q2
  3. 2024 The impact of microscopic extrathyroidal extension on the clinical outcome of classic subtype papillary thyroid microcarcinoma: a multicenter study Endocrine DOI 10.1007/s12020-023-03533-1 YÖKSİS SJR Q2 JCR Q2
  4. 2024 Disease-free survival and the prognostic factors affecting disease-free survival in patients with medullary thyroid carcinoma: a multicenter cohort study Endocrine DOI 10.1007/s12020-024-03809-0 YÖKSİS SJR Q2 JCR Q2
  5. 2024 The impact of microscopic extrathyroidal extension on the clinical outcome of classic subtype papillary thyroid microcarcinoma: a multicenter study Springer Science and Business Media LLC DOI 10.1007/s12020-023-03533-1 YÖKSİS SJR Q2 JCR Q2
  6. 2023 Diagnosis and management of tumor induced osteomalacia: a single center experience. Endocrine DOI 10.1007/s120020-023-03450 YÖKSİS SJR Q2 JCR Q2
  7. 2023 Do Histologically Aggressive Subtypes of Papillary Thyroid Microcarcinoma have Worse Clinical Outcome than Non-Aggressive Papillary Thyroid Microcarcinoma Subtypes? A Multicenter Cohort Study Georg Thieme Verlag KG DOI 10.1055/a-2032-5810 YÖKSİS SJR Q3 JCR Q3
  8. 2023 Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer. Endocrine DOI 10.1007/s12020-023-03427-2 YÖKSİS SJR Q2 JCR Q2
  9. 2023 Do Histologically Aggressive Subtypes of Papillary Thyroid Microcarcinoma have Worse Clinical Outcome than Non-Aggressive Papillary Thyroid Microcarcinoma Subtypes? A Multicenter Cohort Study Hormone and Metabolic Research DOI 10.1055/a-2032-5810 YÖKSİS SJR Q3 JCR Q3
  10. 2023 Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study Journal of Clinical Endocrinology & Metabolism DOI 10.1210/clinem/dgad235 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 93.3%
  11. 2023 Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study The Endocrine Society DOI 10.1210/clinem/dgad235 YÖKSİS SJR Q1 JCR Q1
  12. 2023 Do Histologically Aggressive Subtypes of Papillary Thyroid Microcarcinoma have Worse Clinical Outcome than Non-Aggressive Papillary Thyroid Microcarcinoma Subtypes? A Multicenter Cohort Study The journal Hormone and Metabolic Research DOI 10.1055/a-2032-5810 YÖKSİS SJR Q3 JCR Q3
  13. 2023 Do Histologically Aggressive Subtypes of Papillary Thyroid Microcarcinoma have Worse Clinical Outcome than Non-Aggressive Papillary Thyroid Microcarcinoma Subtypes? A Multicenter Cohort Study Hormone and Metabolic Research DOI 10.1055/a-2032-5810 YÖKSİS SJR Q3 JCR Q3
  14. 2023 Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study The Endocrine Society DOI 10.1210/clinem/dgad235 YÖKSİS SJR Q1 JCR Q1
  15. 2023 The impact of microscopic extrathyroidal extension on the clinical outcome of classic subtype papillary thyroid microcarcinoma: a multicenter study Endocrine DOI 10.1007/s12020-023-03533-1 YÖKSİS SJR Q2 JCR Q2
  16. 2023 Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study J Clin Endocrinol Metab DOI 10.1210/clinem/dgad235 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 93.4%
  17. 2023 Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer ENDOCRINE DOI 10.1007/s12020-023-03427-2 YÖKSİS SJR Q2 JCR Q2
  18. 2023 Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer Endocrine DOI 10.1007/s12020-023-03427-2 YÖKSİS SJR Q2 JCR Q2
  19. 2023 Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study J Clin Endocrinol Metab DOI 10.1210/clinem/dgad235 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 93.3%
  20. 2023 Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study J Clin Endocrinol Metab DOI 10.1210/clinem/dgad235 YÖKSİS SJR Q1 JCR Q1

Akademisyenlere dön